scholarly article | Q13442814 |
P50 | author | Michael Thun | Q19840923 |
Eugenia Calle | Q19904109 | ||
Heather Spencer Feigelson | Q28360663 | ||
S Jane Henley | Q54287866 | ||
Eric Jacobs | Q85550629 | ||
W Dana Flanders | Q92676300 | ||
P2093 | author name string | Carmen Rodriguez | |
Alpa V Patel | |||
Cari J Connell | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | aspirin | Q18216 |
inflammation | Q101991 | ||
P304 | page(s) | 261-4 | |
P577 | publication date | 2005-01-01 | |
P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
P1476 | title | Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort | |
P478 | volume | 14 |
Q34333257 | A review of the reporting and handling of missing data in cohort studies with repeated assessment of exposure measures |
Q58496181 | Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium. |
Q37315498 | Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study |
Q41093416 | Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants. |
Q25257496 | Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer |
Q37386163 | Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study |
Q30367680 | Cyclooxygenase-2 and the inflammogenesis of breast cancer. |
Q34381496 | Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study |
Q28213217 | Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk |
Q39796441 | Medication use and the risk of breast cancer |
Q37216584 | Migraine in postmenopausal women and the risk of invasive breast cancer |
Q43061636 | Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs. |
Q28221965 | NSAIDs and breast cancer recurrence in a prospective cohort study |
Q34069337 | Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study |
Q35711979 | Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study |
Q36678729 | Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study |
Q33811534 | Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women |
Q36727026 | Personalizing Aspirin Use for Targeted Breast Cancer Chemoprevention in Postmenopausal Women |
Q33889458 | Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study |
Q52701379 | Pretreatment neutrophil-to-lymphocyte ratio predicts worse survival outcomes and advanced tumor staging in patients undergoing radical cystectomy for bladder cancer. |
Q35911030 | Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study |
Q37324216 | Regular aspirin use and breast cancer risk in US Black women |
Q38786791 | The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives |
Q36267669 | Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence |
Q37077094 | Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II |
Q28597617 | Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study |
Search more.